Hakam Abu-Zahra
- Cancer Research top 5%
- Breast Cancer Treatment Studies 5
- Carcinogens and Genotoxicity Assessment 3
- Oncology top 5%
- Cancer Treatment and Pharmacology 5
- Neutropenia and Cancer Infections 3
-
- Acute Myeloid Leukemia Research 3
- General Health Professions top 10%
-
- Chronic Lymphocytic Leukemia Research 2
- Blood disorders and treatments 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- B. FindlayAndrew ArnoldMark N. LevineV. BramwellKathleen I. PritchardDavid WarrTed VandenbergRobert G. MacKenzie
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Hakam Abu-Zahra
20 papers receiving 913 citations
Peers
Comparison fields: 5 of 106
- Cancer Research 413
- Oncology 551
- Chemical Health and Safety 5
- Hematology 65
- General Health Professions 143
Countries citing papers authored by Hakam Abu-Zahra
This map shows the geographic impact of Hakam Abu-Zahra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakam Abu-Zahra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakam Abu-Zahra more than expected).
Fields of papers citing papers by Hakam Abu-Zahra
This network shows the impact of papers produced by Hakam Abu-Zahra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakam Abu-Zahra. The network helps show where Hakam Abu-Zahra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hakam Abu-Zahra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 101 | |
| 2 | 2007 | 1 | |
| 3 | 2007 | 1 | |
| 4 | 2006 | 18 | |
| 5 | 2003 | 185 | |
| 6 | 1999 | 36 | |
| 7 | 1998 | 442 | |
| 8 | 1993 | 18 | |
| 9 | 1993 | 5 | |
| 10 | 1992 | 15 | |
| 11 | 1990 | 47 | |
| 12 | 1987 | 10 | |
| 13 | 1980 | 14 | |
| 14 | 1972 | 32 | |
| 15 | Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. | 1972 | 9 |
| 16 | The effect of remission induction in acute myeloblastic leukemia on efficiency of colony formation in culture. | 1972 | 11 |
| 17 | Bone marrow transplantation in patients with acute leukaemia. | 1972 | 4 |
| 18 | 1971 | 6 | |
| 19 | 1970 | 16 | |
| 20 | 1968 | 2 |
About Hakam Abu-Zahra
Hakam Abu-Zahra is a scholar working on Cancer Research, Hematology and Oncology, having authored 20 papers that have together received 973 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Acute Myeloid Leukemia Research (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Neutropenia and Cancer Infections (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Blood disorders and treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Cancer Research (413 citations), Oncology (551 citations) and Chemical Health and Safety (5 citations). Hakam Abu-Zahra has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include B. Findlay, Andrew Arnold, Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, David Warr, Ted Vandenberg, Robert G. MacKenzie, B. Norris and J Robert. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.